A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
Otsuka Pharmaceutical Development & Commercialization, Inc.
Mohit Mathur; Jonathan Barratt; Bobby Chacko; Tak Mao Chan; Laura Kooienga; Kook-Hwan Oh; Manisha Sahay; Yusuke Suzuki; Muh Geot Wong; Jill Yarbrough; Jing Xia; Brian J G Pereira; ENVISION Trial Investigators Group